Elevai Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Revenue	1.71	0.77	0
Revenue Growth (YoY)	123.50%	92557.44%	-
Cost of Revenue	0.58	0.32	0
Gross Profit	1.13	0.45	0
Selling, General & Admin	3.42	1.49	0.33
Research & Development	0.43	0.23	0.12
Other Operating Expenses	1.05	0.52	0.34
Operating Expenses	4.89	2.24	0.79
Operating Income	-3.76	-1.79	-0.79
Interest Expense / Income	0.02	0	0
Other Expense / Income	0.52	0.01	-0
Pretax Income	-4.3	-1.8	-0.78
Net Income	-4.3	-1.8	-0.78
Shares Outstanding (Basic)	11	10	9
Shares Outstanding (Diluted)	11	10	9
Shares Change	12.77%	0.72%	-
EPS (Basic)	-0.40	-0.19	-0.08
EPS (Diluted)	-0.40	-0.19	-0.08
Free Cash Flow	-4.57	-1.62	-0.69
Free Cash Flow Per Share	-0.42	-0.17	-0.07
Gross Margin	66.25%	58.37%	89.36%
Operating Margin	-219.55%	-233.37%	-94928.90%
Profit Margin	-251.17%	-234.94%	-94889.84%
Free Cash Flow Margin	-266.73%	-211.14%	-83847.16%
EBITDA	-4.27	-1.79	-0.78
EBITDA Margin	-249.35%	-233.74%	-94556.47%
Depreciation & Amortization	0.01	0.01	0
EBIT	-4.28	-1.8	-0.78
EBIT Margin	-250.03%	-234.59%	-94889.84%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).